Kerr Holbrook Avanos Medical, Inc. (AVNS) insider trading activity

Kerr Holbrook is SVP, Chief Commercial Officer of AVANOS MEDICAL, INC.. Currently has a direct ownership of 83,860 shares of AVNS, which is worth approximately $955,165. The most recent transaction as insider was on Nov 18, 2025, when has been sold 15,000 shares (Common Stock) at a price of $11.01 per share, resulting in proceeds of $165,150. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 83.9K

15.17% 3M change

2.64% 12M change

Total Value Held $955,165

Kerr Holbrook Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 18 2025	SELL Open market or private sale	$165,150 $11.01 p/Share	15,000 Reduced 15.17%	83,860 Common Stock
Mar 07 2025	BUY Grant, award, or other acquisition	-	22,877 Added 18.79%	98,860 Common Stock
Mar 06 2025	SELL Payment of exercise price or tax liability	$92,779 $15.3 p/Share	6,064 Reduced 7.39%	75,983 Common Stock
Mar 06 2025	SELL Open market or private sale	$106,750 $15.25 p/Share	7,000 Reduced 7.86%	82,047 Common Stock
Mar 04 2025	SELL Payment of exercise price or tax liability	$50,624 $15.13 p/Share	3,346 Reduced 3.62%	89,047 Common Stock
Mar 04 2025	BUY Exercise of conversion of derivative security	-	5,145 Added 5.27%	92,393 Common Stock
Mar 18 2024	SELL Payment of exercise price or tax liability	$68,647 $19.09 p/Share	3,596 Reduced 4.01%	86,131 Common Stock

Mar 18 2024	BUY Exercise of conversion of derivative security	-	2,531 Added 2.74%	89,727 Common Stock
Mar 06 2024	SELL Payment of exercise price or tax liability	$49,742 $19.0 p/Share	2,618 Reduced 2.91%	87,196 Common Stock
Mar 06 2024	BUY Grant, award, or other acquisition	$700,007 $19.14 p/Share	36,573 Added 28.94%	89,814 Common Stock
Mar 05 2024	SELL Payment of exercise price or tax liability	$28,177 $18.76 p/Share	1,502 Reduced 2.79%	52,310 Common Stock
May 08 2023	SELL Payment of exercise price or tax liability	$42,474 $23.97 p/Share	1,772 Reduced 3.19%	53,812 Common Stock
Mar 06 2023	SELL Payment of exercise price or tax liability	$44,815 $29.62 p/Share	1,513 Reduced 2.65%	55,584 Common Stock
Mar 06 2023	BUY Grant, award, or other acquisition	-	24,233 Added 29.8%	57,097 Common Stock
Nov 07 2022	SELL Payment of exercise price or tax liability	$13,991 $22.75 p/Share	615 Reduced 1.88%	32,105 Common Stock
May 09 2022	SELL Payment of exercise price or tax liability	$20,611 $27.74 p/Share	743 Reduced 2.22%	32,720 Common Stock
Mar 04 2022	BUY Grant, award, or other acquisition	-	12,949 Added 27.9%	33,463 Common Stock

Kerr Holbrook

SVP, Chief Commercial Officer

Alpharetta, GA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AVNS shares.

Notify only if

Value

Insider Trading

Get notified when an Avanos Medical, Inc. insider buys or sells AVNS shares.

Notify only if

Operation

Value

Type

News

Receive news related to AVANOS MEDICAL, INC.

Track Activities on AVNS

Account